Nurses’ input leads to new PD protector inside... Gambro DNA Product development and innovation Bloodline safety Extra defence from double membrane technology Clinical corner A round up of the latest dialysis research papers No 23 - APRIL 2008 The CATHcarry protector has been developed after in-depth interviews with experienced nurses and their patients. The result is a product that makes exit site care in PD more effective. It’s actually much more than an effective dressing as it also allows inspection of the exit site, fixes the catheter and immobilizes the extension line, all in one single application. “CATHcarry is made of a thin, waterproof and breathable material which brings noticeable benefits to PD patients such as more freedom to shower,” says Rob Fisher, Home Care Sales and Marketing Manager. “It’s simple to apply Quality of life for peritoneal dialysis patients has received a boost with the launch of Gambro’s new all-in-one PD protector: ‘CATHcarry’. This innovative new dressing supports treatment compliance by letting patients and nurses inspect the exit site at any time - without removing the dressing. cont.page 2 new look To view this issue online visit www.gambro.co.uk/highlights-april08

continued from cover... PD protectors and remove without the need for additional adhesives to maintain the extension line. It also fixes the catheter tightly in the pre-cut catheter slot.” In a prospective open study on 22 patients, CATHcarry (pictured right) was described as easy to apply and remove. The opportunity to shower with CATHcarry was also established as a clinical and qualitative advantage. Also the majority of the study population expressed that they will continue with CATHcarry when commercially available1. Contact Rob Fisher 01480 444000 rob.fisher@gambro.com 1. Grandjean J. et al. CATHcarry, a new hypoallergenic waterproof exit site care product protects the exit site during showers. P-66. at EuRoPD Helsinki, 2007. The HCO 1100 membrane has undergone extensive global in-vitro and in-vivo trials and is currently undergoing in-vivo trial within the UK. Meanwhile the WRO 300 H (see article, right) was launched in the UK on Valentine’s Day and has met with a very positive response for both in-centre and in-home use. Visitors to the BRS/RA Conference in Glasgow can also get a preview of our new AK96 HD machine. You will hear more about this product ahead of its launch towards the end of this year. Of course, all of these developments are only possible because of the commitment to Gambro DNA from all our employees. So in February we held a UK company conference which gave staff further opportunities to have some input into the programme, continuing our approach of staff involvement in innovation. As you can see, we really are working hard to deliver products and services focused on the needs of clinicians and patients. Watch out for more news over the coming months and visit www.gambroDNA.co.uk for more details about our programme of innovation. And the winners are... Thanks to all of you who took the time to complete the form we included with the last edition of Highlights. The exercise has helped us to update our mailing list and means we are better able to issue relevant news and product information to our customers. We also entered everyone who replied into a draw to win a copy of the interesting and informative 80-page book, ‘A tour through Gambro’s history of haemodialysis’. The ten winners were: • Jane Cotterill, Dialysis Services Manager, Birmingham Children's Hospital. • Barbara Kane, Practice Development Nurse, Guy’s Hospital. • Tim Langman, Equipment Library Technician, St Richard’s Hospital, Chichester. • Jane MacDonald, Lead Nurse, Renal Services, Salford Royal Foundation Trust. • Nicky Moncrieff, Renal Nurse Specialist, Addenbrookes Hospital. • Andy Mosson, Chief Technician, Churchill Hospital. • Dr Vadamalai Vivek, Consultant, Russell's Hall Hospital. • Dr Simon Roe, Consultant Nephrologist, Nottingham City Hospital, Nottingham. • Gillian Wood, Senior Staff Nurse, Ninewells Hospital, Dundee. • Jackie Williams, Access Nurse, Wrexham Maelor Hospital. 2 Patient care high on the agenda for Gambro DNA DNA update In the last issue of Highlights we launched Gambro DNA; the programme that is bringing us extensive new investment in product and service development. Since then, we have already seen evidence of the positive contribution the programme will make to patient care. Gareth Jones Country Manager, UK & Ireland